ESTRO
Radio-enhancement by dFdC of a human squamous
cell carcinoma cell line (SQD9)
10 -4
10
-3
10
-2
10 -1
10
0
0
2
4
6
8
10
12
14
Rx alone
dFdC (5 µM) for
3 h prior to Rx
Surviving Fraction
Absorbed dose (Gy)
DMF=1.3
DMF=1.3
DMF=1.3
(Gy
-1
) (Gy
-2
)
Rx
0.30 0.02
Rx + dFdC 0.38 0.04